US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 22.070
  • +1.400+6.77%
Close Sep 13 16:00 ET
  • 22.150
  • +0.080+0.36%
Post 20:02 ET
2.24BMarket Cap-4027P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Development of genome editing-based therapies36.28M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States36.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Gene Editing
Gene Editing
Intraday+1.53%
ARK Portfolio
ARK Portfolio
Intraday+0.61%